Your Top 10 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’ iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network
Carole Soussain, Sylvain Choquet, Marie Blonski, Delphine Leclercq, Caroline Houillier, Keyvan Rezaï and 18 more
- Rank
- 9 of 538
- Percentile
- top 1.7%
- Where
- European Journal of Cancer, 2019
- Citations
- 305
From the 2019 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.